Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Oki

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 17, 2008
Acute lung injury following an esophagectomy for esophageal cancer, with special reference to the clinical factors and cytokine levels of peripheral blood and pleural drainage fluidM Morita, R Yoshida, K Ikeda, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 7, 2014
Splenic volume may be a useful indicator of the protective effect of bevacizumab against oxaliplatin-induced hepatic sinusoidal obstruction syndromeK Imai, Y Emi, K-I Iyama, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 10, 2007
Salvage esophagectomy after definitive chemoradiotherapy for esophageal cancerE Oki, M Morita, Y Kakeji, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
T-cell invigoration to cell-free DNA ratio associated with anti-PD-1 response in gastric or gastro-esophageal junction adenocarcinoma: VOYAGER trialA Makiyama, Q Hu, T Nagasaka, et al.
Transplantation Proceedings|April 21, 2015
Thymoglobulin for steroid-resistant immune-mediated graft dysfunction during simeprevir-based antiviral treatment for post-transplantation hepatitis C: case reportK Takeishi, T Ikegami, T Yoshizumi, et al.
The British Journal of Surgery|May 21, 2020
Alteration in faecal bile acids, gut microbial composition and diversity after laparoscopic sleeve gastrectomyT Ikeda, M Aida, Y Yoshida, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 20, 2015
Evaluation of resectability after neoadjuvant chemotherapy for primary non-resectable colorectal liver metastases: A multicenter studyM Takatsuki, S Tokunaga, S Uchida, et al.
ESMO Open|May 13, 2021
Impact of the 12-gene recurrence score assay on deciding adjuvant chemotherapy for stage II and IIIA/B colon cancer: the SUNRISE-DI studyE Oki, J Watanabe, T Sato, et al.
ESMO Open|December 12, 2025
E7386 in patients with advanced solid tumors: results from the dose-escalation part and an expansion part of a phase I studyS Kondo, N Yamamoto, Y Katsuya, et al.
Transplantation Proceedings|April 21, 2015
Triple therapy using direct-acting agents for recurrent hepatitis C after liver transplantation: a single-center experienceT Ikegami, T Yoshizumi, Y Soejima, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 17, 2008
Acute lung injury following an esophagectomy for esophageal cancer, with special reference to the clinical factors and cytokine levels of peripheral blood and pleural drainage fluidM Morita, R Yoshida, K Ikeda, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 7, 2014
Splenic volume may be a useful indicator of the protective effect of bevacizumab against oxaliplatin-induced hepatic sinusoidal obstruction syndromeK Imai, Y Emi, K-I Iyama, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 10, 2007
Salvage esophagectomy after definitive chemoradiotherapy for esophageal cancerE Oki, M Morita, Y Kakeji, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
T-cell invigoration to cell-free DNA ratio associated with anti-PD-1 response in gastric or gastro-esophageal junction adenocarcinoma: VOYAGER trialA Makiyama, Q Hu, T Nagasaka, et al.
Transplantation Proceedings|April 21, 2015
Thymoglobulin for steroid-resistant immune-mediated graft dysfunction during simeprevir-based antiviral treatment for post-transplantation hepatitis C: case reportK Takeishi, T Ikegami, T Yoshizumi, et al.
The British Journal of Surgery|May 21, 2020
Alteration in faecal bile acids, gut microbial composition and diversity after laparoscopic sleeve gastrectomyT Ikeda, M Aida, Y Yoshida, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 20, 2015
Evaluation of resectability after neoadjuvant chemotherapy for primary non-resectable colorectal liver metastases: A multicenter studyM Takatsuki, S Tokunaga, S Uchida, et al.
ESMO Open|May 13, 2021
Impact of the 12-gene recurrence score assay on deciding adjuvant chemotherapy for stage II and IIIA/B colon cancer: the SUNRISE-DI studyE Oki, J Watanabe, T Sato, et al.
ESMO Open|December 12, 2025
E7386 in patients with advanced solid tumors: results from the dose-escalation part and an expansion part of a phase I studyS Kondo, N Yamamoto, Y Katsuya, et al.
Transplantation Proceedings|April 21, 2015
Triple therapy using direct-acting agents for recurrent hepatitis C after liver transplantation: a single-center experienceT Ikegami, T Yoshizumi, Y Soejima, et al.
Pageof 6